Skip to main content

Day: December 2, 2022

Notice of redemption of convertible bonds PKG5

Notice of redemption of convertible bonds PKG5 AS Pro Kapital Grupp informs that it is redeeming 24 500 “EEK 7.00 PRO KAPITAL GRUPP CONV. BOND PKG5 10-2020” convertible bonds (with ISINEE3300109917) in total nominal value of 245 000 Estonian kroons and issue value of 68 600 euros and has submitted the Nasdaq Central Depository of Securities the application to delete the bonds from the register. The convertible bonds bore an annual interest of 7%. The issue price of each convertible bond was 2.80 euros. The list of bondholders was fixed on 29 November 2022 and redemption payment will be made on 13 December 2022.   Edoardo Axel Preatoni Member of the Management Board +372 614 4920prokapital@prokapital.ee  

Continue reading

Notice of redemption of convertible bonds PKG5

Notice of redemption of convertible bonds PKG5 AS Pro Kapital Grupp informs that it is redeeming 24 500 “EEK 7.00 PRO KAPITAL GRUPP CONV. BOND PKG5 10-2020” convertible bonds (with ISINEE3300109917) in total nominal value of 245 000 Estonian kroons and issue value of 68 600 euros and has submitted the Nasdaq Central Depository of Securities the application to delete the bonds from the register. The convertible bonds bore an annual interest of 7%. The issue price of each convertible bond was 2.80 euros. The list of bondholders was fixed on 29 November 2022 and redemption payment will be made on 13 December 2022.Edoardo Axel Preatoni Member of the Management Board +372 614 4920prokapital@prokapital.ee  

Continue reading

Stelmine acquires three new properties in the de Caniapiscau district

QUEBEC CITY, Dec. 02, 2022 (GLOBE NEWSWIRE) — Stelmine Canada (« Stelmine ») (TSXV : STH). Stelmine maintains its aggressive strategy of acquiring mining properties in the Caniapiscau mining district. The Company is adding 326 new claims to his portfolio bringing the total to 1775 claims covering 936 km2. This scenario allows the Company to protect his dominant land position and develop this new district while taking advantage of high potential mineral targets. In addition to the gold potential, the mineralization discovered on these three new properties should help Stelmine reach its objective of diversifying its portfolio and actively engage in the exploration of strategic metals such as nickel and some base metals while pursuing the advancement of its gold properties. Undoubtedly, during the last five years, Stelmine took the...

Continue reading

Horizon Therapeutics plc

                        FORM 8.3   IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE   1. KEY INFORMATION  Name of person dealing (Note 1) State Street Global Advisors & AffiliatesCompany dealt in Horizon Therapeutics plcClass of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 ordinary sharesDate of dealing 01st Dec 2022       2. INTERESTS AND SHORT POSITIONS   (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)    Long Short  Number (%) Number (%)(1) Relevant securities 5,916,453 2.61001%    (2) Derivatives (other than options) 508 0.000224%    (3) Options and agreements to purchase/sell N/A N/A    Total 5,916,961 2.61024%        (b)...

Continue reading

Horizon Therapeutics plc

                        FORM 8.3   IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE   1. KEY INFORMATION  Name of person dealing (Note 1) State Street Global Advisors & AffiliatesCompany dealt in Horizon Therapeutics plcClass of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 ordinary sharesDate of dealing 29th Nov 2022       2. INTERESTS AND SHORT POSITIONS   (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)    Long Short  Number (%) Number (%)(1) Relevant securities 5,889,421 2.59809%    (2) Derivatives (other than options) 508 0.000224%    (3) Options and agreements to purchase/sell N/A N/A    Total 5,889,929 2.59831%        (b)...

Continue reading

CareCloud To Host Virtual Analyst and Investor Day

SOMERSET, N.J., Dec. 02, 2022 (GLOBE NEWSWIRE) — CareCloud, Inc. (the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced they will host an inaugural Analyst and Investor Day from 1 to 3 p.m. EST on Monday, December 12, 2022 using a live webcast. CareCloud leadership team will use this virtual event to share with participants their historic vision to transform the healthcare industry through high-quality technology, world-class operations and exciting new products. For 20 years, CareCloud has been a pillar in the healthcare technology space, helping healthcare providers deliver a premium, high-value experience for every patient. The Company is at the forefront of the industry’s shift to digitization and a value-based care model, with...

Continue reading

Horizon Therapeutics plc

                        FORM 8.3   IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE   1. KEY INFORMATION  Name of person dealing (Note 1) State Street Global Advisors & AffiliatesCompany dealt in Horizon Therapeutics plcClass of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 ordinary sharesDate of dealing 28th Nov 2022       2. INTERESTS AND SHORT POSITIONS   (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)    Long Short  Number (%) Number (%)(1) Relevant securities 5,905,507 2.60519%    (2) Derivatives (other than options) 508 0.000224%    (3) Options and agreements to purchase/sell N/A N/A    Total 5,906,015 2.60541%        (b)...

Continue reading

SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development

DENVER, COLORADO, Dec. 02, 2022 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq:ICU), (“SeaStar Medical” or the “Company”), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced the appointment of Thomas R. Mullen as Vice President of Operations and Product Development. Mr. Mullen is a proven medical device professional with 30 years of experience leading business operations, manufacturing, engineering, product development and regulatory remediation. “SeaStar Medical has continued to evolve and remains on a trajectory of growth including near-term potential for commercialization. As we continue our preparations for success in treating both acute and chronic illnesses through advanced product offerings, we believe Tom’s extensive...

Continue reading

HIGHCO: Shareholding as 11-30-2022

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF)Date of settlementof information Total number of shares Number of shares without voting rights (*) Number of voting rights for threshold calculation (**) Number of actual voting rights (exercisable at shareholders’ meeting)November 30, 2022 20 455 403 177 280 23 012 201 22 834 921October 31, 2022 20 455 403 145 022 23 048 421 22 903 399September 30, 2022 20 455 403 90 180 23 050 521 22 960 341August 31, 2022 20 455 403 83 843 23 050 522 22 966 679July 31, 2022 20 455 403 82 029 23 050 622 22 968 593July 2, 2022 (***) 20 455 403 78 771 23 050 722 22 971 951June 30, 2022 22 421 332 2 044 700 25 016...

Continue reading

Skyharbour Resources Receives $895,000 from Warrant Exercises

Vancouver, BC, Dec. 02, 2022 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce it has received an aggregate CAD $895,027.32 from the exercise of share purchase warrants with a strike price at $0.22 since June 29th, 2022. A total of 4,068,306 warrants have been exercised with this batch of warrants expiring November 29th, 2022. About Skyharbour Resources Ltd.: Skyharbour holds an extensive portfolio of uranium exploration projects in Canada’s Athabasca Basin and is well positioned to benefit from improving uranium market fundamentals with fifteen projects, ten of which are drill-ready, covering over 450,000 hectares of land. Skyharbour has acquired from Denison Mines, a large strategic shareholder of the Company, a 100% interest in the Moore Uranium...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.